Crinetics pharmaceuticals inc.

Major-Pharmaceuticals

CRNX


Building 2
San Diego , CA 92121

Executive/
Director

Price

  • Last Close
  • $ 53.18
    $ +1.64 3.17 %
    Jan 3, 2025
  • 52-Week High/Low
  • $54.47 - $15.97
  • YTD
  • 4.1%

  • Trading Volume
  • 14,975
  • Market Cap Full
  • $ 3.6B
  • Shares Outstanding
  • 66.8M
    Oct 31, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - -24.1% -5% 8.3% -22.7% -12.2% 31.5% 4.1%
Q2 - - - 11.4% 4% 23.4% -15% 12.2% -6.5% -
Q3 - - 16.9% -38.9% 8% 10.9% 5.3% 65% -1% -
Q4 - - 9.1% 60.4% -10% 35.9% -6.8% 31.1% -9.8% -
J F M A M J J A S O N D
2025 4.1% - - - - - - - - - - -
2024 2.5% 12.2% 14.2% -8.1% 3.4% -2.1% 22.4% -1% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%-18%-42%101%-36%94%44%4%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -2.92 -0.37 -0.71 -0.69 -0.73 -0.85
Q2 - - -2.41 -0.51 -0.53 -0.7 -0.81 -0.94
Q3 - - -0.38 -0.6 -0.56 -0.73 -0.78 -1.01
Q4 - - 3.48 -0.61 -0.62 -0.68 -0.83 -
A 0 0 -2.2 -2.1 -2.4 -2.8 -3.2 -2.8

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 24.1 24.6 33 47784.6 53.9
Jun - 24.1 32.8 37.6 53.5 54
Sep 24 24.2 32.9 38.6 53.8 54.7
Dec 24 24.2 32.9 47.5 53.8 66.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.8 0.2 - 0.2 0.4
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 42 - 75 13.5 14.5
Equity multiplier - - - - -